http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101574339-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a5afaa1be82c1fc3d0485eb44a48bc3b
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
filingDate 2008-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_431d75f9fc215b25dc76553949d764c2
publicationDate 2009-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-101574339-A
titleOfInvention Application of beta-anhydroicaritin in preparation of medicine capable of preventing and treating cardiovascular and cerebrovascular diseases
abstract The invention relates to an application of beta-anhydroicaritin in the preparation of a medicine capable of preventing and treating cardiovascular and cerebrovascular diseases. The pharmacological experiment result of the invention proves that the beta-anhydroicaritin has the obvious functions of preventing and treating the cardiovascular and cerebrovascular diseases, and especially has the obvious functions of preventing and treating the coronary heart disease. The beta-anhydroicaritin and a medicine assistant material which can be accepted in pharmacy are prepared into a medicine composition used for preventing and treating the cardiovascular and cerebrovascular diseases according to a certain mixture ratio. The medicine composition comprises preparation forms, such as tablets, capsules, injection, and the like.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104592246-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105963293-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103271903-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103989696-A
priorityDate 2008-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496755
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426072422
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449847384
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID63351
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10116
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450000382
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID63351
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419499218
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5318997
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449307707
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5318980
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535113
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322514
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4497
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11979961
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID517573
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414850847
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44659717
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14583584
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10116

Total number of triples: 36.